Investing in the Age of Longevity 2023 – David Miles – AKL Therapeutics

David Miles, CEO at AKL Therapeutics, presents at Investing in the Age of Longevity 2023. In his talk, David demonstrates the negative impact of osteoarthritis on healthy aging, and how APPA, a drug under development by AKL, helps address these issues by targeting multiple pathways in osteoarthritis. He also showcases the positive impact that APPA has shown in targeting senescence.

Investing in the Age of Longevity 2023 was held on 16 November 2023. The masterclass featured presentations from scientists and business leaders at the cutting edge of the field, giving participants the inside track on the latest aging-related discoveries and investment opportunities.

Find out more about past and upcoming Master Investor events: https://events.masterinvestor.co.uk